Statin users admitted to hospital for pneumonia are no less likely to die or be admitted to an intensive care unit than non users, according to new Canadian research.
The findings cast doubt on recent observational studies that have reported that patients taking statins at the time they develop pneumonia are less likely to suffer sepsis, die from sepsis or need admitting to ICU.
This latest study looked at 3,415 patients with community acquired pneumonia admitted at six hospitals in Canada and compared the inpatientdeath rates and admission to ICUbetween those taking statinsand those that were not.
Findings show that statin users were less likely to die or be admitted to ICU than non-users 15% compared with 19%. However the potential benefit was outweighed by the potential harm, teh authors concluded.
They suggest anyreduced death rates amongst statin users may be because the drug is more likely to be prescribed to healthy or health seeking patients.
British Medical Journal(2006). Online Publication. DOI:10.1136/bmj.38992.565972.7C